Ren Feng
Amministratore Delegato presso InSilico Medicine Hong Kong Ltd.
Profilo
Ren Feng is currently the Co-CEO, Chief Scientific Officer & Director at InSilico Medicine Hong Kong Ltd.
He holds a doctorate degree from Harvard University.
Posizioni attive di Ren Feng
| Società | Posizione | Inizio |
|---|---|---|
InSilico Medicine Hong Kong Ltd.
 InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | Amministratore Delegato | 15/06/2022 |
Formazione di Ren Feng
| Harvard University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
InSilico Medicine Hong Kong Ltd.
InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | Technology Services |
- Borsa valori
- Insiders
- Ren Feng
